BenevolentAI | Investor Day Presentation Deck | 74 slides

BenevolentAI · 2022-09
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 5
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

74
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
front_matter
04
front_matter
05
summarize
06
diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
07
quantify_opportunity
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
08
The slide uses a hub-and-spoke diagram to show data ingestion into a central AI platform, followed by a list of benefits.present_framework
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
09
Includes a donut chart representing team composition and headshots of the board of directors.establish_context
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
10
front_matter
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
11
transition
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
12
The slide uses two charts to demonstrate market validation: one for investment growth and one for pipeline expansion.analyze_data
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
13
The slide uses a before-after comparison structure to demonstrate the value of AI in pharma R&D.quantify_opportunity
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
14
The slide uses a 2x2 matrix to map specific companies like BenevolentAI, Recursion, Exscientia, Schrodinger, and Relay Therapeutics.present_framework
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
15
The slide uses a linear process flow (1. Data Foundations -> 2. AI Tools) with a circular feedback loop for the AI tools section.present_framework
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
16
Uses a 2x2 matrix to represent the platform approach.present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
17
The slide uses a comparison framework to highlight competitive advantages in drug discovery efficiency.compare_peers
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
18
The chart uses a horizontal bar format to compare IND filing rates against market capitalization for different tiers of pharma companies.compare_peers
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
19
front_matter
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
20
The slide uses a process flow diagram to illustrate the business model, combining a circular platform representation with a linear pipeline and branching commerpresent_solution
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
21
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Scientific, Commercial, Clinical, Data) to specific therapeutic area execution modelspresent_framework
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
22
The slide uses a three-column layout to categorize validation types: Internal Pipeline, Strategic, and Clinical/Regulatory.summarize
Open slide detailBeat · Solution (Provide relief)Loop · Golden Circle
23
The chart uses a timeline-style progression (Hit to Lead through Phase III) to visualize drug development status.analyze_data
Open slide detailBeat · Solution (Provide relief)
24
The slide uses a split-layout with a dark-mode sidebar for AstraZeneca-specific details.illustrate_case
Open slide detailBeat · Solution (Provide relief)
25
The slide uses a list-based structure to demonstrate the value proposition and validation of the company's AI platform.summarize
Open slide detailBeat · Solution (Provide relief)
26
Includes presenter name and title, and company logo.front_matter
Open slide detailBeat · Solution (Provide relief)
27
transition
Open slide detailBeat · Solution (Provide relief)
28
The slide uses a two-stage process flow: 1. Data Foundations (knowledge graph representation) and 2. AI Tools for Scientists (circular workflow).present_solution
Open slide detailBeat · Solution (Provide relief)
29
The slide illustrates a data integration pipeline from raw sources to a knowledge graph representation.present_framework
Open slide detailBeat · Solution (Provide relief)
30
analyze_data
Open slide detailBeat · Solution (Provide relief)
31
The slide uses a process flow diagram to show how raw data inputs are transformed into structured knowledge.present_framework
Open slide detailBeat · Solution (Provide relief)
32
The slide uses a two-part process flow: data ingestion (left) and an iterative AI-driven research cycle (right).present_solution
Open slide detailBeat · Solution (Provide relief)
33
The slide uses a process flow diagram to map out the drug discovery pipeline, specifically focusing on the Target ID phase.present_framework
Open slide detailBeat · Solution (Provide relief)
34
The slide uses a vertical process flow on the left and a detailed 4-quadrant layout for the steps.present_solution
Open slide detailBeat · Solution (Provide relief)
35
The slide shows a process flow on the left (Tech Approach, Predict, Triage, TPA, Assay) and two screenshots of a software interface on the right.present_framework
Open slide detailBeat · Solution (Provide relief)
36
The slide shows a 'Triage Tool' interface. On the left is a process flow diagram (Tech Approach -> Predict -> Triage -> TPA -> Assay) with 'Triage' highlighted.present_solution
Open slide detailBeat · Solution (Provide relief)
37
The slide uses a vertical process flow on the left to indicate the current stage (TPA) within a larger drug discovery pipeline.present_framework
Open slide detailBeat · Solution (Provide relief)
38
present_solution
Open slide detailBeat · Solution (Provide relief)
39
front_matter
Open slide detailBeat · Solution (Provide relief)
40
Uses a circular diagram to represent the feedback loop between lab work and data integration.present_solution
Open slide detailBeat · Solution (Provide relief)
41
The chart uses a swimlane-style visualization to show progress across drug discovery stages (Target ID to Phase III).analyze_data
Open slide detailBeat · Solution (Provide relief)
42
Includes a clinical photograph of the condition.frame_problem
Open slide detailBeat · Solution (Provide relief)
43
Includes a biological mechanism diagram showing NGF, BDNF, and NTF-3 binding to TrkA, TrkB, and TrkC receptors.present_solution
Open slide detailBeat · Solution (Provide relief)
44
The slide uses a complex biological illustration to map specific receptor pathways to cellular mechanisms in AD skin.diagnose_problem
Open slide detailBeat · Solution (Provide relief)
45
Includes data on T-cell activation inhibition, sensory neuron activation, and mouse ear inflammation reduction.summarize
Open slide detailBeat · Solution (Provide relief)
46
The slide uses a process flow diagram to illustrate an adaptive clinical trial design.present_framework
Open slide detailBeat · Solution (Provide relief)
47
The slide uses a flow-chart to illustrate an adaptive clinical trial design.present_framework
Open slide detailBeat · Solution (Provide relief)
48
Includes specific caveats regarding small sample size and short duration.analyze_data
Open slide detailBeat · Solution (Provide relief)
49
The slide outlines a clinical trial process flow with specific durations and patient ratios.present_framework
Open slide detailBeat · Solution (Provide relief)
50
The slide uses a visual treatment flow diagram to contrast current and future treatment options.propose_solution
Open slide detailBeat · Solution (Provide relief)
51
introduce_nominees
Open slide detailBeat · Solution (Provide relief)
52
Includes a process diagram for biopsy analysis and a market segmentation breakdown.diagnose_problem
Open slide detailBeat · Solution (Provide relief)
53
The slide demonstrates the inhibitory effect of anti-TNF monoclonal antibodies on cytokine release.analyze_data
Open slide detailBeat · Solution (Provide relief)
54
The slide displays protein phosphorylation intensity across various markers for healthy vs. inflamed tissue.analyze_data
Open slide detailBeat · Solution (Provide relief)
55
The slide contains four dose-response curves (a-d) and two box-and-whisker plots (e-f) showing cytokine levels in patient biopsies.analyze_data
Open slide detailBeat · Solution (Provide relief)
56
The slide outlines a drug discovery pipeline starting from a biological question, moving through computational target identification, and ending with experimentpresent_solution
Open slide detailBeat · Solution (Provide relief)
57
The slide uses a combination of a biological pathway diagram, scatter plots for differential expression, and a line chart for tissue-specific expression.diagnose_problem
Open slide detailBeat · Solution (Provide relief)
58
The slide uses a process diagram to explain the experimental setup and bar charts to show the efficacy of the compound in reducing IL-6 and IL-8 levels.present_solution
Open slide detailBeat · Solution (Provide relief)
59
The slide uses a causal flow diagram to link PDE10 inhibition to therapeutic outcomes in IBD.present_solution
Open slide detailBeat · Solution (Provide relief)
60
The slide uses a combination of a horizontal timeline graphic and three vertical columns detailing specific development phases.present_solution
Open slide detailBeat · Solution (Provide relief)
61
compare_peers
Open slide detailBeat · Solution (Provide relief)
62
The chart uses a Gantt-like structure to represent drug development stages (Target ID to Phase III).present_solution
Open slide detailBeat · Solution (Provide relief)
63
The slide uses a process flow diagram to illustrate the integration of AI-driven precision medicine into the standard pharmaceutical R&D lifecycle.present_solution
Open slide detailBeat · Solution (Provide relief)
64
plan_implementation
Open slide detailBeat · Solution (Provide relief)
65
front_matter
Open slide detailBeat · Solution (Provide relief)
66
summarize
Open slide detailBeat · Solution (Provide relief)
67
The table shows financial results for the six months ended 30 June 2022 vs 2021. Expenses are shown in parentheses indicating negative values.analyze_data
Open slide detailBeat · Solution (Provide relief)
68
The slide explains the impact of non-recurring business combination costs on the operating loss.analyze_data
Open slide detailBeat · Solution (Provide relief)
69
The slide reconciles operating loss to cash expended from underlying operating activities and shows the movement in cash balance.analyze_data
Open slide detailBeat · Solution (Provide relief)
70
The slide uses a hub-and-spoke diagram to link the company to five specific capital allocation priorities.plan_implementation
Open slide detailBeat · Solution (Provide relief)
71
summarize
Open slide detailBeat · Solution (Provide relief)
72
summarize
Open slide detailBeat · Solution (Provide relief)
73
summarize
Open slide detailBeat · Solution (Provide relief)
74
summarize
Open slide detailBeat · Solution (Provide relief)